Viewing StudyNCT00058422



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00058422
Status: COMPLETED
Last Update Posted: 2020-11-12
First Post: 2003-04-07

Brief Title: Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-02-10
Start Date Type: ACTUAL
Primary Completion Date: 2019-11-14
Primary Completion Date Type: ACTUAL
Completion Date: 2019-11-14
Completion Date Type: ACTUAL
First Submit Date: 2003-04-07
First Submit QC Date: April 8 2003
Study First Post Date: 2003-04-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2020-11-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-10-19
Last Update Post Date: 2020-11-12
Last Update Post Date Type: ACTUAL